# Portfolio Project Template: Multi-Target Drug Discovery Pipeline

## Project Overview
This is a comprehensive portfolio project that demonstrates your ability to apply computational drug discovery techniques to real-world challenges. You'll build a complete pipeline for analyzing multiple drug targets and developing predictive models.

## Learning Integration
This project integrates concepts from:
- **Week 1-2**: Python/ML basics and cheminformatics
- **Week 3-4**: Advanced ML and neural networks
- **Week 5-6**: Molecular modeling and simulation
- **Week 7-8**: Quantum chemistry and computing
- **Week 9-10**: Drug design and optimization
- **Week 11-12**: Integration and validation

## Project Structure
```
portfolio_project/
├── README.md                    # This file
├── data/                        # Raw and processed datasets
├── notebooks/                   # Analysis notebooks
│   ├── 01_data_exploration.ipynb
│   ├── 02_descriptor_analysis.ipynb
│   ├── 03_model_development.ipynb
│   ├── 04_validation_testing.ipynb
│   └── 05_results_summary.ipynb
├── src/                         # Source code modules
│   ├── data_processing.py
│   ├── feature_engineering.py
│   ├── modeling.py
│   ├── validation.py
│   └── visualization.py
├── results/                     # Outputs and reports
├── tests/                       # Unit tests
└── requirements.txt             # Dependencies
```

## Phase 1: Foundation (Weeks 1-4)

### Milestone 1.1: Data Collection and Preprocessing
**Timeline**: End of Week 2
**Deliverables**:
- [ ] Multi-target dataset compilation (minimum 3 targets)
- [ ] Data quality assessment report
- [ ] Standardized molecular preprocessing pipeline
- [ ] Initial exploratory data analysis

**Targets Suggested**:
- BACE-1 (Alzheimer's disease)
- hERG (cardiotoxicity)
- CYP3A4 (drug metabolism)

**Assessment Criteria**:
- Data quality and completeness
- Preprocessing pipeline robustness
- Visualization quality
- Documentation clarity

### Milestone 1.2: Molecular Descriptor Analysis
**Timeline**: End of Week 4
**Deliverables**:
- [ ] Comprehensive descriptor calculation (2D/3D)
- [ ] Feature selection and importance analysis
- [ ] Cross-target descriptor comparison
- [ ] Drug-likeness assessment across targets

**Technical Requirements**:
- Minimum 50 molecular descriptors per compound
- Statistical analysis of descriptor distributions
- Feature correlation analysis
- Lipinski and other drug-likeness rules

## Phase 2: Model Development (Weeks 5-8)

### Milestone 2.1: Classical ML Models
**Timeline**: End of Week 6
**Deliverables**:
- [ ] Multiple algorithm comparison (RF, SVM, XGBoost)
- [ ] Cross-validation framework
- [ ] Hyperparameter optimization
- [ ] Model interpretability analysis

### Milestone 2.2: Deep Learning Implementation
**Timeline**: End of Week 8
**Deliverables**:
- [ ] Neural network architectures for each target
- [ ] Graph neural network implementation
- [ ] Transfer learning between targets
- [ ] Performance comparison with classical methods

## Phase 3: Advanced Techniques (Weeks 9-12)

### Milestone 3.1: Multi-Target Modeling
**Timeline**: End of Week 10
**Deliverables**:
- [ ] Multi-task learning implementation
- [ ] Target similarity analysis
- [ ] Shared representation learning
- [ ] Cross-target prediction validation

### Milestone 3.2: Integration and Validation
**Timeline**: End of Week 12
**Deliverables**:
- [ ] External validation on held-out datasets
- [ ] Prospective validation design
- [ ] Model deployment pipeline
- [ ] Comprehensive project report

## Assessment Framework

### Technical Excellence (40%)
- Code quality and documentation
- Proper use of version control
- Test coverage and validation
- Performance optimization

### Scientific Rigor (35%)
- Appropriate methodology selection
- Statistical significance testing
- Proper validation strategies
- Literature integration

### Innovation and Insight (15%)
- Novel approaches or improvements
- Deep understanding demonstration
- Creative problem-solving
- Future work identification

### Communication (10%)
- Clear documentation and reporting
- Effective visualizations
- Presentation quality
- Reproducibility

## Progress Tracking Checkpoints

### Weekly Check-ins
- **Week 2**: Data collection and initial analysis
- **Week 4**: Descriptor analysis and feature engineering
- **Week 6**: Classical ML model comparison
- **Week 8**: Deep learning implementation
- **Week 10**: Multi-target modeling
- **Week 12**: Final validation and reporting

### Self-Assessment Questions
1. How does your model performance compare to published benchmarks?
2. What are the key molecular features driving predictions for each target?
3. How well do models trained on one target generalize to others?
4. What are the limitations of your current approach?
5. How would you improve the pipeline for future work?

## Resources and References

### Required Reading
- Computational Drug Discovery and Design (Springer)
- Deep Learning for the Life Sciences (O'Reilly)
- Best Practices for QSAR Model Development

### Software Tools
- RDKit for cheminformatics
- DeepChem for deep learning
- PyTorch/TensorFlow for neural networks
- MLflow for experiment tracking
- Weights & Biases for model monitoring

### Datasets
- ChEMBL database
- PubChem bioassay data
- ZINC database for molecular diversity
- TDC (Therapeutics Data Commons)

## Peer Review Process

### Review Schedule
- **Week 4**: Data and descriptor analysis peer review
- **Week 8**: Model development peer review
- **Week 12**: Final project peer review

### Review Criteria
- Technical correctness
- Code quality and reproducibility
- Scientific insight and interpretation
- Presentation clarity

### Review Template
```markdown
## Peer Review for [Student Name]

### Strengths
- List 3-5 strong aspects of the work

### Areas for Improvement
- Specific suggestions for enhancement

### Technical Comments
- Code quality observations
- Methodology suggestions

### Questions for Author
- Clarification requests
- Discussion points

### Overall Rating: [1-5 scale]
```

## Final Presentation Guidelines

### Presentation Structure (20 minutes + 10 minutes Q&A)
1. **Introduction** (3 min): Problem statement and objectives
2. **Methods** (5 min): Data and modeling approach
3. **Results** (8 min): Key findings and model performance
4. **Discussion** (3 min): Insights and limitations
5. **Future Work** (1 min): Next steps and improvements

### Evaluation Criteria
- Scientific content quality
- Presentation clarity
- Time management
- Question handling
- Visual aid effectiveness

## Success Metrics

### Minimum Requirements
- [ ] Complete all milestone deliverables
- [ ] Achieve R² > 0.6 for at least 2 targets
- [ ] Document reproducible workflow
- [ ] Pass peer review criteria
- [ ] Present final results

### Excellence Indicators
- [ ] Innovative methodology application
- [ ] Superior model performance
- [ ] Insightful cross-target analysis
- [ ] High-quality code and documentation
- [ ] Significant contribution to understanding

## Support Resources

### Office Hours
- Mondays 2-4 PM: Technical support
- Wednesdays 1-3 PM: Scientific discussion
- Fridays 3-5 PM: Presentation practice

### Communication Channels
- Slack: #portfolio-projects
- Email: [instructor email]
- GitHub: Repository for code review

### Emergency Support
For urgent technical issues or deadline concerns, contact the instructor directly.

---

**Remember**: This portfolio project is your opportunity to demonstrate comprehensive mastery of computational drug discovery. Focus on quality over quantity, and don't hesitate to ask for help when needed!
